Nico M Wulffraat Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

4/2022	Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study.
1/2022	Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use.
1/2022	Perspectives of Pediatric Rheumatologists on Initiating and Tapering Biologics in Patients with Juvenile Idiopathic Arthritis: A Formative Qualitative Study.
12/2021	Association of adalimumab trough concentrations and treatment response in patients with juvenile idiopathic arthritis.
12/2020	Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study.
2/2020	Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance.
1/2020	The Patient and Parent Perspective on Methotrexate in Recent Juvenile Idiopathic Arthritis Guidelines: Comment on the Article by Ringold et al.
10/2019	Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients.
1/2019	Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study.
12/2018	Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nico M Wulffraat Research Topics

Disease

50	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2022 - 02/2003
13	Arthritis (Polyarthritis) 01/2016 - 02/2011
7	Infections 01/2021 - 02/2004
7	Rheumatic Diseases (Rheumatism) 01/2019 - 06/2012
6	Uveitis 01/2018 - 04/2013
6	Autoimmune Diseases (Autoimmune Disease) 12/2017 - 11/2006
4	Rheumatoid Arthritis 01/2019 - 01/2013
4	Necrosis 01/2018 - 02/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 09/2013
3	Dermatomyositis (Dermatopolymyositis) 01/2016 - 05/2013
3	Inflammation (Inflammations) 01/2015 - 05/2007
3	Pain (Aches) 01/2015 - 04/2013
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 07/2011
2	Poliomyelitis (Polio) 01/2020 - 03/2018
2	Macrophage Activation Syndrome 10/2019 - 03/2010
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2019 - 05/2013
2	Psoriatic Arthritis 09/2014 - 01/2013
2	Measles 06/2013 - 06/2012
2	Rubella (German Measles) 06/2013 - 06/2012
2	Mumps 06/2013 - 06/2012
2	Neoplasms (Cancer) 01/2013 - 11/2006
2	Tetanus 06/2012 - 02/2007
1	COVID-19 01/2021
1	Fever (Fevers) 12/2020
1	Hepatitis B 01/2019
1	Spondylitis 01/2019
1	Diarrhea 03/2018
1	Fatigue 02/2018
1	Crohn Disease (Crohn's Disease) 12/2017
1	Systemic Scleroderma (Systemic Sclerosis) 12/2017
1	Proteinuria 12/2017
1	Reticular dysgenesis 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Mucopolysaccharidosis I (Hurler Syndrome) 03/2015
1	Negative rheumatoid factor polyarthritis 02/2015
1	Experimental Arthritis 02/2014
1	Tuberculosis (Tuberculoses) 01/2013
1	Diphtheria 06/2012
1	Hypersensitivity (Allergy) 03/2012

Drug/Important Bio-Agent (IBA)

16	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 07/2011
9	Biological ProductsIBA 07/2015 - 02/2011
8	Etanercept (Enbrel)FDA Link 01/2022 - 03/2010
8	VaccinesIBA 01/2021 - 11/2011
7	Antirheumatic Agents (DMARD)IBA 04/2022 - 01/2014
6	Pharmaceutical PreparationsIBA 04/2017 - 09/2012
4	Adalimumab (Humira)FDA Link 12/2021 - 10/2011
4	canakinumab FDA Link 12/2020 - 04/2013
3	Antinuclear AntibodiesIBA 01/2019 - 01/2015
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2014 - 11/2004
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019 - 04/2014
2	Rheumatoid FactorIBA 01/2019 - 09/2014
2	InterleukinsIBA 03/2018 - 04/2013
2	Interleukin-6 (Interleukin 6)IBA 03/2018 - 12/2013
2	Proteoglycans (Proteoglycan)IBA 01/2016 - 02/2014
2	Biomarkers (Surrogate Marker)IBA 02/2015 - 06/2014
2	CytokinesIBA 09/2014 - 05/2007
2	Papillomavirus Vaccines (HPV Vaccines)IBA 08/2014 - 09/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 10/2011
2	Tumor Necrosis Factor InhibitorsIBA 09/2013 - 02/2011
2	AntibodiesIBA 01/2013 - 06/2012
2	Immunoglobulin G (IgG)IBA 06/2012 - 02/2007
2	EnzymesIBA 04/2011 - 02/2007
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 11/2007 - 02/2003
1	amsonic acid (DAS)IBA 12/2021
1	GlucocorticoidsIBA 12/2020
1	SolutionsIBA 02/2020
1	tocilizumab (atlizumab)FDA Link 10/2019
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019
1	Attenuated VaccinesIBA 03/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Amino Acids FDA Link 01/2018
1	Prednisone (Sone)FDA LinkGeneric 12/2017
1	Antiphospholipid AntibodiesIBA 10/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2015
1	methotrexate polyglutamateIBA 02/2015
1	C-Reactive ProteinIBA 02/2015
1	CreatinineIBA 01/2015
1	Interleukin-1 (Interleukin 1)IBA 01/2015
1	Alanine Transaminase (SGPT)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 06/2014
1	S100A12 ProteinIBA 06/2014
1	SteroidsIBA 04/2014
1	NAD (NADH)IBA 12/2013
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2013
1	Creatine Kinase (Creatine Phosphokinase)IBA 05/2013
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 05/2013
1	Monoclonal AntibodiesIBA 04/2013
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 06/2012

Therapy/Procedure

10	Therapeutics 02/2020 - 11/2006
5	Stem Cell Transplantation 04/2017 - 06/2004
3	Biological Therapy 01/2022 - 12/2011
3	Transplantation 12/2017 - 09/2010
3	Hematopoietic Stem Cell Transplantation 12/2017 - 09/2010
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016 - 11/2006
1	Drug Tapering 12/2020
1	Pain Management 02/2018
1	Patient Transfer (Patient Dumping) 01/2018
1	Cell Transplantation 03/2015